Skip to main content

Animations

MJFF Publications

5611 - 5620 of 8808 Results
Title
Year
  • Year
  • 2023
  • 2024
  • 2024
  • 2023
  • 2023
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: Prediction of dyskinesia in Parkinson’s disease patients using machine learning algorithms
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-49617-w
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Design and high-throughput implementation of MALDI-TOF/MS-based assays for Parkin E3 ligase activity
    Journal Name: Cell Reports Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.crmeth.2024.100712
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Genetic and multi‐omic risk assessment of Alzheimer's disease implicates core associated biological domains
    Journal Name: Alzheimer's & Dementia: Translational Research & Clinical Interventions
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/trc2.12461
    Citation Count: 23
  • Summary Details
    RESTRICTED
    Title: Differences in Sex‐Specific Frequency of Glucocerebrosidase Variant Carriers and Familial Parkinsonism
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29353
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Duodenal alpha‐Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29358
    Citation Count: 34
  • Summary Details
    OPEN
    Title: A topographical atlas of α-synuclein dosage and cell type-specific expression in adult mouse brain and peripheral organs
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00672-8
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-46832-5
    Citation Count: 40
  • Summary Details
    OPEN
    Title: Spatial transcriptomics reveals molecular dysfunction associated with cortical Lewy pathology
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-47027-8
    Citation Count: 51
  • Summary Details
    OPEN
    Title: Reduced progranulin increases tau and α-synuclein inclusions and alters mouse tauopathy phenotypes via glucocerebrosidase
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-45692-3
    Citation Count: 14
  • Summary Details
    OPEN
    Title: RASP: Optimal Single Puncta Detection in Complex Cellular Backgrounds
    Journal Name: The Journal of Physical Chemistry B
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/acs.jpcb.4c00174
    Citation Count: 3
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.